APO Research
Talk to an analyst

APO RESEARCH · REPORT

Filgrastim

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Filgrastim Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025170 pages

Choose your research edition.

Industry ResearchFilgrastim Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgrastim Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Filgrastim Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgrastim Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgrastim Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Filgrastim market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Filgrastim include SANDOZ INC, Amgen and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Filgrastim market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Filgrastim and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Filgrastim sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Filgrastim market size, projected growth trends, production technologies, key applications, and end-use industries.

Filgrastim Segment by Company

SANDOZ INC

Amgen

Teva

Filgrastim Segment by Type

Lyophilized Powder

Others

Filgrastim Segment by Application

Solid Tumor

Kidney Cancer

Lymphoma

Lung Disease

Others

Filgrastim Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgrastim and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Filgrastim market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Filgrastim manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Filgrastim in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Filgrastim in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Filgrastim Industry Trends Table 2. Filgrastim Industry Drivers Table 3. Filgrastim Industry Opportunities and Challenges Table 4. Filgrastim Industry Restraints Table 5. Global Filgrastim Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Filgrastim Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Filgrastim Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Filgrastim Sales Market Share by Manufacturers Table 9. Global Filgrastim Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Filgrastim Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Filgrastim Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Filgrastim Manufacturers, Product Type & Application Table 13. Global Filgrastim Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Filgrastim by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lyophilized Powder Table 17. Major Manufacturers of Others Table 18. Global Filgrastim Sales by Type 2021 VS 2025 VS 2032 (tons) Table 19. Global Filgrastim Sales by Type (2021-2026) & (tons) Table 20. Global Filgrastim Sales by Type (2027-2032) & (tons) Table 21. Global Filgrastim Sales Market Share by Type (2021-2026) Table 22. Global Filgrastim Sales Market Share by Type (2027-2032) Table 23. Global Filgrastim Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 24. Global Filgrastim Revenue by Type (2021-2026) & (tons) Table 25. Global Filgrastim Revenue by Type (2027-2032) & (tons) Table 26. Global Filgrastim Revenue Market Share by Type (2021-2026) Table 27. Global Filgrastim Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Solid Tumor Table 29. Major Manufacturers of Kidney Cancer Table 30. Major Manufacturers of Lymphoma Table 31. Major Manufacturers of Lung Disease Table 32. Major Manufacturers of Others Table 33. Global Filgrastim Sales by Application 2021 VS 2025 VS 2032 (tons) Table 34. Global Filgrastim Sales by Application (2021-2026) & (tons) Table 35. Global Filgrastim Sales by Application (2027-2032) & (tons) Table 36. Global Filgrastim Sales Market Share by Application (2021-2026) Table 37. Global Filgrastim Sales Market Share by Application (2027-2032) Table 38. Global Filgrastim Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 39. Global Filgrastim Revenue by Application (2021-2026) & (tons) Table 40. Global Filgrastim Revenue by Application (2027-2032) & (tons) Table 41. Global Filgrastim Revenue Market Share by Application (2021-2026) Table 42. Global Filgrastim Revenue Market Share by Application (2027-2032) Table 43. Global Filgrastim Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 44. Global Filgrastim Sales by Region (2021-2026) & (tons) Table 45. Global Filgrastim Sales Market Share by Region (2021-2026) Table 46. Global Filgrastim Sales Forecasted by Region (2027-2032) & (tons) Table 47. Global Filgrastim Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 49. North America Filgrastim Sales by Country (2021-2026) & (tons) Table 50. North America Filgrastim Sales by Country (2027-2032) & (tons) Table 51. Europe Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 52. Europe Filgrastim Sales by Country (2021-2026) & (tons) Table 53. Europe Filgrastim Sales by Country (2027-2032) & (tons) Table 54. Asia Pacific Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 55. Asia Pacific Filgrastim Sales by Country (2021-2026) & (tons) Table 56. Asia Pacific Filgrastim Sales by Country (2027-2032) & (tons) Table 57. South America, Middle East and Africa Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 58. South America, Middle East and Africa Filgrastim Sales by Country (2021-2026) & (tons) Table 59. South America, Middle East and Africa Filgrastim Sales by Country (2027-2032) & (tons) Table 60. Global Filgrastim Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Filgrastim Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Filgrastim Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Filgrastim Revenue Market Share by Region (2021-2026) Table 64. Global Filgrastim Revenue Market Share by Region (2027-2032) Table 65. SANDOZ INC Company Information Table 66. SANDOZ INC Business Overview Table 67. SANDOZ INC Filgrastim Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. SANDOZ INC Filgrastim Product Portfolio Table 69. SANDOZ INC Recent Development Table 70. Amgen Company Information Table 71. Amgen Business Overview Table 72. Amgen Filgrastim Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Amgen Filgrastim Product Portfolio Table 74. Amgen Recent Development Table 75. Teva Company Information Table 76. Teva Business Overview Table 77. Teva Filgrastim Sales (tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Teva Filgrastim Product Portfolio Table 79. Teva Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Filgrastim Distributors List Table 83. Filgrastim Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Filgrastim Product Image Figure 2. Global Filgrastim Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgrastim Market Size (2021-2032) & (US$ Million) Figure 4. Global Filgrastim Sales (2021-2032) & (tons) Figure 5. Global Filgrastim Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Filgrastim Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lyophilized Powder Image Figure 9. Others Image Figure 10. Global Filgrastim Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 11. Global Filgrastim Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Filgrastim Sales Market Share by Type (2021-2032) Figure 13. Global Filgrastim Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Filgrastim Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Filgrastim Revenue Market Share by Type (2021-2032) Figure 16. Solid Tumor Image Figure 17. Kidney Cancer Image Figure 18. Lymphoma Image Figure 19. Lung Disease Image Figure 20. Others Image Figure 21. Global Filgrastim Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 22. Global Filgrastim Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Filgrastim Sales Market Share by Application (2021-2032) Figure 24. Global Filgrastim Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 25. Global Filgrastim Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Filgrastim Revenue Market Share by Application (2021-2032) Figure 27. North America Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 28. North America Filgrastim Sales Market Share by Country (2021-2032) Figure 29. U.S. Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 30. Canada Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 31. Mexico Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 32. Europe Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 33. Europe Filgrastim Sales Market Share by Country (2021-2032) Figure 34. Germany Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 35. France Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 36. U.K. Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 37. Italy Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 38. Netherlands Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 39. Asia Pacific Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 40. Asia Pacific Filgrastim Sales Market Share by Country (2021-2032) Figure 41. China Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 42. Japan Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 43. South Korea Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 44. Southeast Asia Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 45. India Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 46. Australia Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 47. South America, Middle East and Africa Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 48. South America, Middle East and Africa Filgrastim Sales Market Share by Country (2021-2032) Figure 49. Brazil Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 50. South Africa Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 51. Saudi Arabia Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 52. Turkey Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 53. Argentina Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 54. UAE Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 55. Egypt Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 56. Chile Filgrastim Sales and Growth Rate (2021-2032) & (tons) Figure 57. Global Filgrastim Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Filgrastim Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Filgrastim Revenue (2021-2032) & (US$ Million) Figure 60. North America Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Filgrastim Revenue (2021-2032) & (US$ Million) Figure 62. Europe Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Filgrastim Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Filgrastim Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Filgrastim Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Filgrastim Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized Powder
  • Others
Applications
  • Solid Tumor
  • Kidney Cancer
  • Lymphoma
  • Lung Disease
  • Others
Companies covered
  • SANDOZ INC
  • Amgen
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Filgrastim Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Filgrastim Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Filgrastim Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Filgrastim Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Filgrastim Market Dynamics
  1. 2.1 Filgrastim Industry Trends
  2. 2.2 Filgrastim Industry Drivers
  3. 2.3 Filgrastim Industry Opportunities and Challenges
  4. 2.4 Filgrastim Industry Restraints
3 Filgrastim Market by Manufacturers
  1. 3.1 Global Filgrastim Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Filgrastim Sales by Manufacturers (2021-2026)
  3. 3.3 Global Filgrastim Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Filgrastim Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Filgrastim Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Filgrastim Manufacturers, Product Type & Application
  7. 3.7 Global Filgrastim Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Filgrastim Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Filgrastim Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Filgrastim Tier 1, Tier 2, and Tier 3
4 Filgrastim Market by Type
  1. 4.1 Filgrastim Type Introduction
  2. 4.1.1 Lyophilized Powder
  3. 4.1.2 Others
  4. 4.2 Global Filgrastim Sales by Type
  5. 4.2.1 Global Filgrastim Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Filgrastim Sales by Type (2021-2032)
  7. 4.2.3 Global Filgrastim Sales Market Share by Type (2021-2032)
  8. 4.3 Global Filgrastim Revenue by Type
  9. 4.3.1 Global Filgrastim Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Filgrastim Revenue by Type (2021-2032)
  11. 4.3.3 Global Filgrastim Revenue Market Share by Type (2021-2032)
5 Filgrastim Market by Application
  1. 5.1 Filgrastim Application Introduction
  2. 5.1.1 Solid Tumor
  3. 5.1.2 Kidney Cancer
  4. 5.1.3 Lymphoma
  5. 5.1.4 Lung Disease
  6. 5.1.5 Others
  7. 5.2 Global Filgrastim Sales by Application
  8. 5.2.1 Global Filgrastim Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Filgrastim Sales by Application (2021-2032)
  10. 5.2.3 Global Filgrastim Sales Market Share by Application (2021-2032)
  11. 5.3 Global Filgrastim Revenue by Application
  12. 5.3.1 Global Filgrastim Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Filgrastim Revenue by Application (2021-2032)
  14. 5.3.3 Global Filgrastim Revenue Market Share by Application (2021-2032)
6 Global Filgrastim Sales by Region
  1. 6.1 Global Filgrastim Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Filgrastim Sales by Region (2021-2032)
  3. 6.2.1 Global Filgrastim Sales by Region (2021-2026)
  4. 6.2.2 Global Filgrastim Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Filgrastim Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Filgrastim Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Filgrastim Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Filgrastim Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Filgrastim Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Filgrastim Revenue by Region
  1. 7.1 Global Filgrastim Revenue by Region
  2. 7.1.1 Global Filgrastim Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Filgrastim Revenue by Region (2021-2026)
  4. 7.1.3 Global Filgrastim Revenue by Region (2027-2032)
  5. 7.1.4 Global Filgrastim Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Filgrastim Revenue (2021-2032)
  8. 7.2.2 North America Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Filgrastim Revenue (2021-2032)
  11. 7.3.2 Europe Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Filgrastim Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Filgrastim Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Filgrastim Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 SANDOZ INC
  2. 8.1.1 SANDOZ INC Company Information
  3. 8.1.2 SANDOZ INC Business Overview
  4. 8.1.3 SANDOZ INC Filgrastim Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SANDOZ INC Filgrastim Product Portfolio
  6. 8.1.5 SANDOZ INC Recent Developments
  7. 8.2 Amgen
  8. 8.2.1 Amgen Company Information
  9. 8.2.2 Amgen Business Overview
  10. 8.2.3 Amgen Filgrastim Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amgen Filgrastim Product Portfolio
  12. 8.2.5 Amgen Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Filgrastim Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Filgrastim Product Portfolio
  18. 8.3.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Filgrastim Value Chain Analysis
  2. 9.1.1 Filgrastim Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Filgrastim Production Mode & Process
  6. 9.2 Filgrastim Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Filgrastim Distributors
  9. 9.2.3 Filgrastim Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst